Beyond the Petri dish: Testing tomorrow's drugs in human blood

Дата публикации: 27-08-2026 19:00:01

The COVID vaccine is perhaps the first thing many people think of when they hear about mRNA-based drugs. Small packages of genetic material are sent into the body, prompting cells to produce useful proteins in the fight against the virus. But the list of diseases that can potentially be treated with mRNA-based drugs is much broader than vaccines. mRNA is expected to be used to treat disorders including cardiovascular diseases, rare hereditary diseases and autoimmune diseases—and not least, cancer.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies	0	5.03	20-08-2026
2	Alternative mRNA modification lets ribosomes move nearly twice as fast	0	12.07	20-08-2026
3	В Минздраве отметили прогресс в создании в России препаратов для терапии редких болезней	0	0	03-04-2023
4	В Москве создадут 11 биомолекул для лечения рака и аутоиммунных болезней	0	13.67	21-08-2026
5	Stable RNA elements open new possibilities for mRNA therapeutics	0	7.83	14-08-2026
6	Body's own cell-to-cell messaging packets studied as the basis for next-generation medicines	5	8	12-07-2026
7	National Institutes of Health testing controversial Covid drug as new cancer treatment	0	8.01	11-02-2026
8	DNA origami vaccines could be the next leap beyond mRNA	0	7.91	17-03-2026
9	What is Moderna’s new cancer vaccine and how big a breakthrough is it?	0	6.64	20-08-2026
10	Inherited gene variants may shape CAR-T therapy benefits and toxic side effects	0	8.44	24-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.95. Источник: phys.org.